Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
-3.12%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
+$32.1M
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| 1 |
Broadcom
AVGO
|
+$195M |
| 2 |
Brown-Forman Class B
BF.B
|
+$128M |
| 3 |
UnitedHealth
UNH
|
+$127M |
| 4 |
Waste Management
WM
|
+$93.2M |
| 5 |
Arch Capital
ACGL
|
+$89.6M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 2 |
Pfizer
PFE
|
+$108M |
| 3 |
Target
TGT
|
+$108M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$106M |
| 5 |
Micron Technology
MU
|
+$105M |
Sector Composition
| 1 | Technology | 31.47% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Sutro Biopharma
STRO
$75M
| $381K | ﹤0.01% |
68,684
| – | – |
|
|
BPMC
1002
DELISTED
Blueprint Medicines
BPMC
| $380K | ﹤0.01% |
+5,762
| New | +$380K |
|
1003
Flywire
FLYW
$1.65B
| $380K | ﹤0.01% |
+16,570
| New | +$380K |
|
1004
Northfield Bancorp
NFBK
$494M
| $379K | ﹤0.01% |
26,485
+4,850
| +22% | +$69.4K |
|
|
SIVB
1005
DELISTED
SVB Financial Group
SIVB
| $379K | ﹤0.01% |
1,128
+361
| +47% | +$121K |
|
1006
PMV Pharmaceuticals
PMVP
$66.2M
| $378K | ﹤0.01% |
31,790
+320
| +1% | +$3.81K |
|
1007
US Foods
USFD
$18B
| $375K | ﹤0.01% |
14,188
| – | – |
|
|
ITCI
1008
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $375K | ﹤0.01% |
+8,054
| New | +$375K |
|
1009
Unitil
UTL
$829M
| $373K | ﹤0.01% |
8,032
-9,318
| -54% | -$433K |
|
1010
Cerus
CERS
$238M
| $372K | ﹤0.01% |
103,232
+22,019
| +27% | +$79.3K |
|
|
AEL
1011
DELISTED
American Equity Investment Life Holding Company
AEL
| $372K | ﹤0.01% |
9,964
-570
| -5% | -$21.3K |
|
1012
Legend Biotech
LEGN
$6.11B
| $371K | ﹤0.01% |
9,087
| – | – |
|
1013
Prothena Corp
PRTA
$448M
| $370K | ﹤0.01% |
+6,106
| New | +$370K |
|
|
CMRC
1014
Commerce.com, Inc. Series 1 Common Stock
CMRC
$372M
| $368K | ﹤0.01% |
24,898
| – | – |
|
1015
Mirum Pharmaceuticals
MIRM
$3.78B
| $368K | ﹤0.01% |
17,533
-12,087
| -41% | -$254K |
|
1016
Entergy
ETR
$40.5B
| $367K | ﹤0.01% |
7,286
-2,500
| -26% | -$126K |
|
1017
RLX Technology
RLX
$3.2B
| $367K | ﹤0.01% |
+349,655
| New | +$367K |
|
1018
Interface
TILE
$1.66B
| $367K | ﹤0.01% |
40,807
+15,496
| +61% | +$139K |
|
1019
Peoples Bancorp
PEBO
$1.09B
| $365K | ﹤0.01% |
12,610
| – | – |
|
1020
Ziff Davis
ZD
$1.52B
| $365K | ﹤0.01% |
5,326
-2,808
| -35% | -$192K |
|
1021
Moelis & Co
MC
$5.56B
| $364K | ﹤0.01% |
10,777
-35,286
| -77% | -$1.19M |
|
|
EVRI
1022
DELISTED
Everi Holdings
EVRI
| $363K | ﹤0.01% |
22,409
-2,736
| -11% | -$44.3K |
|
1023
PTC
PTC
$24.6B
| $363K | ﹤0.01% |
+3,470
| New | +$363K |
|
1024
Stoke Therapeutics
STOK
$1.24B
| $362K | ﹤0.01% |
28,223
| – | – |
|
1025
Usana Health Sciences
USNA
$560M
| $359K | ﹤0.01% |
6,406
-2,085
| -25% | -$117K |
|